© 2020 MJH Life Sciences and Practical Cardiology. All rights reserved.
© 2020 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
September 21, 2020
Chief member of Practical Cardiology's editorial advisory board discusses his approach to cholesterol education and the current state of cholesterol management in 2020.
September 06, 2020
Lead investigator of the PARALLAX trial discusses whether he feels clinical data related to sacubitril/valsartan is strong enough to warrant prescribing it for HFpEF patients.
September 04, 2020
Deepak Bhatt, MD, of Brigham and Women's Hospital, offers perspective on REDUCE-IT analyses and icosapent ethyl (Vascepa) data presented at ESC Congress 2020.
September 03, 2020
Milton Packer, MD, discusses how EMPEROR-Reduced data influences the way clinicians view the SGLT2 inhibitor class and its uses.
August 24, 2020
A physician from New York City discusses her experiences treating and suffering from coronavirus disease 2019 (COVID-19) during her work at a medical intensive care unit at Mount Sinai.
August 10, 2020
A new scientific statement from the American Heart Association is acting as a "call to action" for greater research into the effects of marijuana, according to the statement's co-author.
August 01, 2020
A practicing endocrinologist discusses his reaction to topline results from EMPEROR-REDUCED and what he hopes to see in the presentation at ESC 2020.
July 23, 2020
Guy Mintz, MD, discusses life as a practicing cardiologist during the ongoing COVID-19 pandemic.
October 11, 2016
Study questions whether reduction in AF burden after catheter ablation leads to sustained beneficial cardiac remodeling.
September 19, 2016
What outcomes do you expect from this study? One modifiable risk factor is actually in your hands.